Results 111 to 120 of about 458,270 (348)

Enzyme-Based Labeling Strategies for Antibody–Drug Conjugates and Antibody Mimetics

open access: yesAntibodies, 2018
Strategies for site-specific modification of proteins have increased in number, complexity, and specificity over the last years. Such modifications hold the promise to broaden the use of existing biopharmaceuticals or to tailor novel proteins for ...
Georg Falck, Kristian M. Müller
doaj   +1 more source

Exploiting metabolic adaptations to overcome dabrafenib treatment resistance in melanoma cells

open access: yesMolecular Oncology, EarlyView.
We show that dabrafenib‐resistant melanoma cells undergo mitochondrial remodeling, leading to elevated respiration and ROS production balanced by stronger antioxidant defenses. This altered redox state promotes survival despite mitochondrial damage but renders resistant cells highly vulnerable to ROS‐inducing compounds such as PEITC, highlighting redox
Silvia Eller   +17 more
wiley   +1 more source

Evaluation of color-coded drug labeling to identify endovenous medicines

open access: yesRevista Brasileira de Enfermagem
Objective: To analyze the opinion of nursing professionals on the design, practicality of use and the usefulness of color-coded drug labeling in a pediatric intensive care unit. Methods: A cross-sectional study with 42 nursing professionals.
Nayana Maria Gomes de Souza   +4 more
doaj   +1 more source

It Depends on What the Meaning of False is: Falsity and Misleadingness in Commercial Speech Doctrine [PDF]

open access: yes, 2007
While scholarship regarding the Supreme Court\u27s noncommercial speech doctrine has often focused on the level of protection for truthful, non-misleading commercial speech, scholars have paid little attention to the exclusion of false or misleading ...
Tushnet, Rebecca
core   +2 more sources

Outcomes of off-label drug uses in hospitals: a multicentric prospective study [PDF]

open access: hybrid, 2014
Imma Danés   +12 more
openalex   +1 more source

ATF4‐mediated stress response as a therapeutic vulnerability in chordoma

open access: yesMolecular Oncology, EarlyView.
We screened 5 chordoma cell lines against 100+ inhibitors of epigenetic and metabolic pathways and kinases and identified halofuginone, a tRNA synthetase inhibitor. Mechanistically halofuginone induces an integrated stress response, with eIF2alpha phosphorylation, activation of ATF4 and its target genes CHOP, ASNS, INHBE leading to cell death ...
Lucia Cottone   +11 more
wiley   +1 more source

Research of ddi based on multi-label conditional random field

open access: yesBIO Web of Conferences, 2017
The detection of drug name and drug-drug interaction(DDI) is considered as a sequence labeling task in this paper. We present the multi-label CRF method to complete it.
Yu Yangzhi, Deng Hongtao, Zhu Xun
doaj   +1 more source

O-102 Analyses Of Current Unlicensed And Off-label For Age Drug Prescriptions At A Neonatal Intensive Care Unit: Abstract O-102 Table 1 [PDF]

open access: bronze, 2014
RB Flint   +5 more
openalex   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

Home - About - Disclaimer - Privacy